Literature DB >> 18317941

Exploring structure-selectivity relationships of biogenic amine GPCR antagonists using similarity searching and dynamic compound mapping.

Ingo Vogt1, Hany E A Ahmed, Jens Auer, Jürgen Bajorath.   

Abstract

We design and analyze compound selectivity sets of antagonists with differential selectivity against seven biogenic amine G-protein coupled receptors. The selectivity sets consist of a total of 267 antagonists and contain a spectrum of in part closely related molecular scaffolds. Each set represents a different selectivity profile. Using these com- pound sets, a systematic computational analysis of structure-selectivity relationships is carried out with different 2D similarity methods including fingerprints, recursive partitioning, clustering, and dynamic compound mapping. Screening calculations are performed in a background database containing nearly four million molecules. Fingerprint searching and compound mapping are found to enrich target-selective antagonists over family-selective ones. Dynamic compound mapping effectively discriminates database compounds from GPCR antagonists and consistently retains target-selective antagonists during the final dimension extension levels. Furthermore, the widely used MACCS key fingerprint displays a strong tendency to distinguish between target- and family-selective GPCR antagonists. Taken together, the results indicate that different types of 2D similarity methods are capable of distinguishing closely related molecules having different selectivity. The reported compound benchmark system is made freely available in order to enable selectivity-oriented analyses using other computational approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317941     DOI: 10.1007/s11030-008-9071-2

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  49 in total

1.  Retrospective analysis of an experimental high-throughput screening data set by recursive partitioning.

Authors:  A M van Rhee; J Stocker; D Printzenhoff; C Creech; P K Wagoner; K L Spear
Journal:  J Comb Chem       Date:  2001 May-Jun

2.  Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.

Authors:  He Zhao; Xiaoshu He; Andrew Thurkauf; Diane Hoffman; Andrzej Kieltyka; Robbin Brodbeck; Renee Primus; Jan W F Wasley
Journal:  Bioorg Med Chem Lett       Date:  2002-11-04       Impact factor: 2.823

Review 3.  Chemical genetics to chemical genomics: small molecules offer big insights.

Authors:  David R Spring
Journal:  Chem Soc Rev       Date:  2005-06       Impact factor: 54.564

4.  Global mapping of pharmacological space.

Authors:  Gaia V Paolini; Richard H B Shapland; Willem P van Hoorn; Jonathan S Mason; Andrew L Hopkins
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

Review 5.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

6.  Methods for computer-aided chemical biology. Part 2: Evaluation of compound selectivity using 2D molecular fingerprints.

Authors:  Ingo Vogt; Dagmar Stumpfe; Hany E A Ahmed; Jürgen Bajorath
Journal:  Chem Biol Drug Des       Date:  2007-09       Impact factor: 2.817

7.  Methods for computer-aided chemical biology. Part 1: Design of a benchmark system for the evaluation of compound selectivity.

Authors:  Dagmar Stumpfe; Hany E A Ahmed; Ingo Vogt; Jürgen Bajorath
Journal:  Chem Biol Drug Des       Date:  2007-09       Impact factor: 2.817

Review 8.  The discovery of potent and selective dopamine D4 receptor antagonists.

Authors:  W S Faraci; S H Zorn; M A Sanner; A Fliri
Journal:  Curr Opin Chem Biol       Date:  1998-08       Impact factor: 8.822

9.  Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors.

Authors:  B E Maryanoff; D F McComsey; G E Martin; R P Shank
Journal:  Bioorg Med Chem Lett       Date:  1998-04-21       Impact factor: 2.823

10.  1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.

Authors:  Timo Heinrich; Henning Böttcher; Helmut Prücher; Rudolf Gottschlich; Karl-August Ackermann; Christoph van Amsterdam
Journal:  ChemMedChem       Date:  2006-02       Impact factor: 3.466

View more
  6 in total

1.  Information properties of naturally-occurring proteins: Fourier analysis and complexity phase plots.

Authors:  Daniel J Graham; Shelby Grzetic; Donald May; John Zumpf
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

2.  Identification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening.

Authors:  Ralf Mueller; Alice L Rodriguez; Eric S Dawson; Mariusz Butkiewicz; Thuy T Nguyen; Stephen Oleszkiewicz; Annalen Bleckmann; C David Weaver; Craig W Lindsley; P Jeffrey Conn; Jens Meiler
Journal:  ACS Chem Neurosci       Date:  2010-01-28       Impact factor: 4.418

3.  Freely available compound data sets and software tools for chemoinformatics and computational medicinal chemistry applications.

Authors:  Ye Hu; Jurgen Bajorath
Journal:  F1000Res       Date:  2012-08-14

4.  CFam: a chemical families database based on iterative selection of functional seeds and seed-directed compound clustering.

Authors:  Cheng Zhang; Lin Tao; Chu Qin; Peng Zhang; Shangying Chen; Xian Zeng; Feng Xu; Zhe Chen; Sheng Yong Yang; Yu Zong Chen
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

5.  Follow up: Compound data sets and software tools for chemoinformatics and medicinal chemistry applications: update and data transfer.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  F1000Res       Date:  2014-03-11

6.  An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs.

Authors:  Jie Xia; Hongwei Jin; Zhenming Liu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2014-05-01       Impact factor: 4.956

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.